These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32602143)

  • 1. Recurrence beyond the Milan criteria after curative-intent resection of hepatocellular carcinoma: A novel tumor-burden based prediction model.
    Tsilimigras DI; Mehta R; Guglielmi A; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    J Surg Oncol; 2020 Oct; 122(5):955-963. PubMed ID: 32602143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria.
    Tsilimigras DI; Mehta R; Paredes AZ; Moris D; Sahara K; Bagante F; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Spolverato G; Umberto C; Pawlik TM
    Ann Surg; 2020 Oct; 272(4):574-581. PubMed ID: 32932309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort.
    Zheng J; Chou JF; Gönen M; Vachharajani N; Chapman WC; Majella Doyle MB; Turcotte S; Vandenbroucke-Menu F; Lapointe R; Buettner S; Groot Koerkamp B; Ijzermans JNM; Chan CY; Goh BKP; Teo JY; Kam JH; Jeyaraj PR; Cheow PC; Chung AYF; Chow PKH; Ooi LLPJ; Balachandran VP; Kingham TP; Allen PJ; D'Angelica MI; DeMatteo RP; Jarnagin WR; Lee SY
    Ann Surg; 2017 Oct; 266(4):693-701. PubMed ID: 28650354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant.
    Mehta N; Heimbach J; Harnois DM; Sapisochin G; Dodge JL; Lee D; Burns JM; Sanchez W; Greig PD; Grant DR; Roberts JP; Yao FY
    JAMA Oncol; 2017 Apr; 3(4):493-500. PubMed ID: 27838698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
    J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting recurrence patterns after resection of hepatocellular cancer.
    Lee SY; Konstantinidis IT; Eaton AA; Gönen M; Kingham TP; D'Angelica MI; Allen PJ; Fong Y; DeMatteo RP; Jarnagin WR
    HPB (Oxford); 2014 Oct; 16(10):943-53. PubMed ID: 25041404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Liver Resection for Solitary Hepatocellular Carcinoma.
    Kim JM; Joh JW; Yi NJ; Choi GS; Kim K; Lee KW; Suh KS
    J Gastrointest Surg; 2020 Oct; 24(10):2219-2227. PubMed ID: 31482410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
    Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines.
    Tsilimigras DI; Mehta R; Moris D; Sahara K; Bagante F; Paredes AZ; Farooq A; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    Ann Surg Oncol; 2020 Mar; 27(3):866-874. PubMed ID: 31696396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinoma.
    Ho CM; Wu CY; Lee PH; Lai HS; Ho MC; Wu YM; Hu RH
    Ann Surg Oncol; 2013 Aug; 20(8):2526-33. PubMed ID: 23504121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TBS-Based Preoperative Score to Predict Non-transplantable Recurrence and Identify Candidates for Upfront Resection Versus Transplantation for Hepatocellular Carcinoma.
    Lima HA; Moazzam Z; Endo Y; Alaimo L; Shaikh C; Munir MM; Resende V; Guglielmi A; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Hugh T; Endo I; Kitago M; Shen F; Pawlik TM
    Ann Surg Oncol; 2023 Jun; 30(6):3363-3373. PubMed ID: 36820934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.
    Lei Z; Li J; Wu D; Xia Y; Wang Q; Si A; Wang K; Wan X; Lau WY; Wu M; Shen F
    JAMA Surg; 2016 Apr; 151(4):356-63. PubMed ID: 26579636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group.
    Vitale A; Lai Q; Farinati F; Bucci L; Giannini EG; Napoli L; Ciccarese F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Sacco R; Cabibbo G; Virdone R; Marra F; Felder M; Morisco F; Benvegnù L; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Missale G; Masotto A; Nardone G; Colecchia A; Bernardi M; Trevisani F; Pawlik TM;
    J Gastrointest Surg; 2018 May; 22(5):859-871. PubMed ID: 29352441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors for extrahepatic recurrence of hepatocellular carcinoma following liver transplantation.
    Andreou A; Bahra M; Schmelzle M; Öllinger R; Sucher R; Sauer IM; Guel-Klein S; Struecker B; Eurich D; Klein F; Pascher A; Pratschke J; Seehofer D
    Clin Transplant; 2016 Jul; 30(7):819-27. PubMed ID: 27107252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of tumor burden score on timing and patterns of recurrence after curative-intent resection of hepatocellular carcinoma.
    Moazzam Z; Lima HA; Alaimo L; Endo Y; Shaikh CF; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    Surgery; 2022 Nov; 172(5):1448-1455. PubMed ID: 36031442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Tumor Markers Provide Refined Prognostication in Selecting Liver Transplantation Candidate for Hepatocellular Carcinoma Patients Beyond the Milan Criteria.
    Lee JH; Cho Y; Kim HY; Cho EJ; Lee DH; Yu SJ; Lee JW; Yi NJ; Lee KW; Kim SH; Kim JM; Joh JW; Teperman LW; Park JS; Kim YJ; Suh KS; Yoon JH
    Ann Surg; 2016 May; 263(5):842-50. PubMed ID: 26779979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milan criteria, multi-nodularity, and microvascular invasion predict the recurrence patterns of hepatocellular carcinoma after resection.
    Hung HH; Lei HJ; Chau GY; Su CW; Hsia CY; Kao WY; Lui WY; Wu WC; Lin HC; Wu JC
    J Gastrointest Surg; 2013 Apr; 17(4):702-11. PubMed ID: 23225107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does meeting the Milan criteria at the time of recurrence of hepatocellular carcinoma after curative resection have an impact on prognosis?
    Kim HS; Yi NJ; Kim JM; Hong SK; Kwon CHD; Joh JW; Lee KW; Suh KS
    ANZ J Surg; 2019 Mar; 89(3):216-222. PubMed ID: 30384395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
    Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
    Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.